Orthobiologic Treatments for Your Practice in Irvine, CA

What I’d check before adding orthobiologic treatments here

Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 8.3% of adults in Irvine have diagnosed diabetes — 3.7 points below the U.S. 12% figure. 5% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick orthobiologic treatments against that mix.

Cash PRP and Medicare CTPs in the same hallway

• CDC PLACES (2023, crude) estimates 8.3% of adults in Irvine have diagnosed diabetes — 3.7 points below the U.S. 12% figure. Adult arthritis here is 14.1% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Separate 361 tissue, PRP, and CTP tickets before you market orthobiologic treatments in Irvine. Mixing lanes is how recoupments start.
• Non-opioid pain pathways (PRP, orthobiologics) still need diagnosis codes that justify the procedure. California payers will not treat “patient prefers regenerative” as medical necessity.
• Medicare wound-care biologics in California are paid under Noridian Healthcare Solutions (JE). CTP and skin-substitute LCDs are MAC-specific — a protocol that billed cleanly in another jurisdiction can stall here if documentation does not match JE coverage articles.

Uninsured mix and Medicare CTPs in the same building

America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Irvine we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 8.3% of adults in Irvine have diagnosed diabetes — 3.7 points below the U.S. 12% figure.

How we’d stand this up in clinic